デフォルト表紙
市場調査レポート
商品コード
1386591

ショートリードシーケンスの世界市場:動向、予測、競合分析(~2030年)

Short-Read Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ショートリードシーケンスの世界市場:動向、予測、競合分析(~2030年)
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ショートリードシーケンスの動向と予測

世界のショートリードシーケンスの市場規模は、2024~2030年にかけてCAGR 18.9%で成長し、2030年までに約171億米ドルに達すると予測されています。この市場の主な促進要因は、研究および臨床センターからの需要の増加と個別化医療への嗜好の高まりです。世界のショートリードシーケンス市場の将来は、学術・研究機関、病院・診療所、製薬・バイオテクノロジー市場にビジネスチャンスがあり、有望視されています。

ショートリードシーケンス市場の洞察

Lucintelの予測では、よりシンプルで時間がかからず、分析がより正確になり、精度が向上するため、標的セグメントが引き続き最大となります。

この市場において、学術・研究機関は引き続き最大セグメントです。

北米は、強固なヘルスケアインフラの存在、研究開発に対する政府資金の増加、同地域における主要プレイヤーの存在により、引き続き最大の地域となるであろう。

本レポートでは、以下の11の主要な質問に回答しています:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えるか?

目次

第1章 エグゼクティブサマリー

第2章 世界のショートリードシーケンス市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析:2018~2030年

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界のショートリードシーケンス市場の動向(2018~2023年)と予測(2024~2030年)
  • 世界のショートリードシーケンス市場:製品タイプ別
    • 機器
    • 消耗品
    • サービス
  • 世界のショートリードシーケンス市場:ワークフロー別
    • プレシーケンス
    • シーケンス
    • データ分析
  • 世界のショートリードシーケンス市場:用途別
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
    • その他
  • 世界のショートリードシーケンス市場:最終用途別
    • 学術・研究機関
    • 病院・診療所
    • 製薬・バイオテクノロジー
    • その他

第4章 市場動向と予測分析:地域別(2018~2030年)

  • 世界のショートリードシーケンス市場:地域別
  • 北米のショートリードシーケンス市場
  • 欧州のショートリードシーケンス市場
  • アジア太平洋のショートリードシーケンス市場
  • その他の地域のショートリードシーケンス市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界のショートリードシーケンス市場の成長機会
    • ワークフロー別の世界のショートリードシーケンス市場の成長機会
    • 用途別の世界のショートリードシーケンス市場の成長機会
    • 最終用途別の世界のショートリードシーケンス市場の成長機会
    • 地域別の世界のショートリードシーケンス市場の成長機会
  • 世界のショートリードシーケンス市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のショートリードシーケンス市場の生産能力拡大
    • 世界のショートリードシーケンス市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences of California
  • BGI
  • QIAGEN
  • Agilent Technologies
  • Psomagen
  • Azenta
  • PerkinElmer
  • ProPhase Labs
目次

Short-Read Sequencing Trends and Forecast

The future of the global short-read sequencing market looks promising with opportunities in the academic & research institute, hospital & clinic, and pharmaceutical & biotechnology markets. The global short-read sequencing market is expected to reach an estimated $17.1 billion by 2030 with a CAGR of 18.9% from 2024 to 2030. The major drivers for this market are growing demand from research and clinical centers and increasing preference for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Short-Read Sequencing by Segment

The study includes a forecast for the global short-read sequencing by product type, workflow, application, end use, and region.

Short-Read Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Short-Read Sequencing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Short-Read Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing
  • Others

Short-Read Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology
  • Others

Short-Read Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Short-Read Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies short-read sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the short-read sequencing companies profiled in this report include-

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences of California
  • BGI
  • QIAGEN
  • Agilent Technologies
  • Psomagen
  • Azenta
  • PerkinElmer
  • ProPhase Labs

Short-Read Sequencing Market Insights

Lucintel forecasts that targeted will remain the largest segment as it is simpler, less time-consuming, makes analysis more precise, and increases accuracy.

Within this market, academic and research institute will remain the largest segment.

North America wil remain the largest region due to existence of robust healthcare infrastructure, rising favourable government funding for research and development, and presence of key players in the region.

Features of the Global Short-Read Sequencing Market

Market Size Estimates: Short-read sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Short-read sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of ($B).

Regional Analysis: Short-read sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, workflows, applications, end uses, and regions for the short-read sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the short-read sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the short-read sequencing market size?

Answer: The global short-read sequencing market is expected to reach an estimated $17.1 billion by 2030.

Q.2 What is the growth forecast for short-read sequencing market?

Answer: The global short-read sequencing market is expected to grow with a CAGR of 18.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the short-read sequencing market?

Answer: The major drivers for this market are growing demand from research and clinical centers and increasing preference for personalized medicine.

Q4. What are the major segments for short-read sequencing market?

Answer: The future of the short-read sequencing market looks promising with opportunities in the academic & research institute, hospital & clinic, and pharmaceutical & biotechnology markets.

Q5. Who are the key short-read sequencing market companies?

Answer: Some of the key short-read sequencing companies are as follows:

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences of California
  • BGI
  • QIAGEN
  • Agilent Technologies
  • Psomagen
  • Azenta
  • PerkinElmer
  • ProPhase Labs

Q6. Which short-read sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that targeted will remain the largest segment as it is simpler, less time-consuming, makes analysis more precise, and increases accuracy.

Q7. In short-read sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America wil remain the largest region due to existence of robust healthcare infrastructure, rising favourable government funding for research and development, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the short-read sequencing market by product type (instruments, consumables, and services), workflow (pre-sequencing, sequencing, and data analysis), application (whole genome sequencing, whole exome sequencing, targeted sequencing & resequencing, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Short-Read Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Short-Read Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Short-Read Sequencing Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Services
  • 3.4: Global Short-Read Sequencing Market by Workflow
    • 3.4.1: Pre-Sequencing
    • 3.4.2: Sequencing
    • 3.4.3: Data Analysis
  • 3.5: Global Short-Read Sequencing Market by Application
    • 3.5.1: Whole Genome Sequencing
    • 3.5.2: Whole Exome Sequencing
    • 3.5.3: Targeted Sequencing & Resequencing
    • 3.5.4: Others
  • 3.6: Global Short-Read Sequencing Market by End Use
    • 3.6.1: Academic & Research Institutes
    • 3.6.2: Hospitals & Clinics
    • 3.6.3: Pharmaceutical & Biotechnology
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Short-Read Sequencing Market by Region
  • 4.2: North American Short-Read Sequencing Market
    • 4.2.1: North American Short-Read Sequencing Market by Application: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, and Others
    • 4.2.2: North American Short-Read Sequencing Market by End Use: Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.3: European Short-Read Sequencing Market
    • 4.3.1: European Short-Read Sequencing Market by Application: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, and Others
    • 4.3.2: European Short-Read Sequencing Market by End Use: Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.4: APAC Short-Read Sequencing Market
    • 4.4.1: APAC Short-Read Sequencing Market by Application: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, and Others
    • 4.4.2: APAC Short-Read Sequencing Market by End Use: Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology, and Others
  • 4.5: ROW Short-Read Sequencing Market
    • 4.5.1: ROW Short-Read Sequencing Market by Application: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing, and Others
    • 4.5.2: ROW Short-Read Sequencing Market by End Use: Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Short-Read Sequencing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Short-Read Sequencing Market by Workflow
    • 6.1.3: Growth Opportunities for the Global Short-Read Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global Short-Read Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Short-Read Sequencing Market by Region
  • 6.2: Emerging Trends in the Global Short-Read Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Short-Read Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Short-Read Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Illumina
  • 7.2: Thermo Fisher Scientific
  • 7.3: Pacific Biosciences of California
  • 7.4: BGI
  • 7.5: QIAGEN
  • 7.6: Agilent Technologies
  • 7.7: Psomagen
  • 7.8: Azenta
  • 7.9: PerkinElmer
  • 7.10: ProPhase Labs